Nifty

:

25114.00

Sensex

:

81904.70

108.50 (0.43%)
355.97 (0.44%)

Login

Nifty
Sensex

:
:

25114.00
81904.70

108.50 (0.43%)
355.97 (0.44%)

Aarti Drugs Ltd.

Pharmaceuticals & Drugs - API

Rating :

58/99

BSE: 524348 | NSE: AARTIDRUGS

Watchlist

NSE BSE

509.65

12-Sep-2025

Open
High
Low
Previous Close

514.65
515
505.8
511.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

129448
66137154.6
564.05
312

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,651.58
24.64
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,256.26
0.20%
3.27

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.67
2.07
-4.21

EBITDA CAGR (%)

10 Years
5 Years
3 Years

4.90
-8.00
-1.27

PAT CAGR (%)

10 Years
5 Years
3 Years

9.36
-9.72
0.37

P:E (Median)

8 Years
5 Years
3 Years

22.51
24.15
25.33

P:BV (Average)

8 Years
5 Years
3 Years

3.98
4.53
3.50

EV:EBITDA (Average)

8 Years
5 Years
3 Years

13.37
15.63
15.62

Earnings Forecasts:

(Updated: 08-09-2025)

Description 2024 2025 2026 2027
Adj EPS 18.35 23.2 28.3
P/E Ratio 27.77 21.97 18.01
Revenue 2387.03 2688.3 3027.1
EBITDA 287.06 373.7 438.9
Net Income 168.16 212.1 257.9
ROA 6.72
P/B Ratio 3.40 3.04 2.70
ROE 12.69 14.6 15.9
FCFF 46.19
FCFF Yield 0.86
Net Debt 607.51
BVPS 149.99 167.4 188.6

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 520.96 492.96 5.68% 622.96 559.53 11.34% 514.54 538.21 -4.40% 543.09 577.54 -5.96%
Expenses 457.01 438.74 4.16% 534.30 490.47 8.94% 454.29 478.47 -5.05% 483.55 512.12 -5.58%
EBITDA 63.95 54.22 17.95% 88.66 69.06 28.38% 60.25 59.74 0.85% 59.54 65.42 -8.99%
EBIDTM 12.28% 11.00% 14.23% 12.34% 11.71% 11.10% 10.96% 11.33%
Other Income 0.38 0.11 245.45% 1.71 1.11 54.05% 11.37 1.68 576.79% 0.38 0.74 -48.65%
Interest 6.82 7.46 -8.58% 7.48 8.09 -7.54% 7.57 6.75 12.15% 7.17 7.55 -5.03%
Depreciation 12.27 11.71 4.78% 12.21 12.34 -1.05% 12.02 11.80 1.86% 11.86 11.78 0.68%
PBT 45.24 35.16 28.67% 70.68 49.74 42.10% 52.03 42.87 21.37% 40.89 46.83 -12.68%
Tax -3.40 8.25 - 9.20 13.60 -32.35% 13.50 11.25 20.00% 10.50 12.25 -14.29%
PAT 48.64 26.91 80.75% 61.48 36.14 70.12% 38.53 31.62 21.85% 30.39 34.58 -12.12%
PATM 9.34% 5.46% 9.87% 6.46% 7.49% 5.88% 5.60% 5.99%
EPS 5.33 2.95 80.68% 6.73 3.96 69.95% 4.22 3.46 21.97% 3.33 3.79 -12.14%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 590.51 555.34 6.33% 676.76 619.99 9.16% 556.60 605.94 -8.14% 598.33 641.54 -6.74%
Expenses 516.43 490.38 5.31% 583.44 534.18 9.22% 494.87 535.80 -7.64% 531.28 565.09 -5.98%
EBITDA 74.08 64.96 14.04% 93.32 85.81 8.75% 61.73 70.14 -11.99% 67.05 76.45 -12.30%
EBIDTM 12.55% 11.70% 13.79% 13.84% 11.09% 11.58% 11.21% 11.92%
Other Income 0.31 1.11 -72.07% 1.87 1.08 73.15% 11.90 1.67 612.57% 1.48 0.68 117.65%
Interest 8.56 8.71 -1.72% 9.16 9.13 0.33% 9.07 7.60 19.34% 8.93 8.25 8.24%
Depreciation 14.72 13.38 10.01% 14.88 13.58 9.57% 13.80 12.66 9.00% 13.72 12.61 8.80%
PBT 51.11 43.98 16.21% 71.15 64.18 10.86% 50.76 51.55 -1.53% 45.88 56.27 -18.46%
Tax -2.86 10.71 - 8.38 16.87 -50.33% 13.67 14.84 -7.88% 10.92 16.67 -34.49%
PAT 53.97 33.27 62.22% 62.77 47.31 32.68% 37.09 36.71 1.04% 34.96 39.60 -11.72%
PATM 9.14% 5.99% 9.28% 7.63% 6.66% 6.06% 5.84% 6.17%
EPS 5.91 3.62 63.26% 6.89 5.15 33.79% 4.06 3.99 1.75% 3.84 4.31 -10.90%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,201.55 2,173.65 2,266.91 2,497.97 2,251.17 1,914.89 1,634.92 1,454.25 1,140.46 1,088.72 1,075.50 Net Sales Growth 1.54% -4.11% -9.25% 10.96% 17.56% 17.12% 12.42% 27.51% 4.75% 1.23% Cost Of Goods Sold 1,432.11 1,374.50 1,479.38 1,690.45 1,456.26 1,122.09 1,028.03 950.77 686.64 673.19 690.90 Gross Profit 769.44 799.16 787.53 807.52 794.92 792.80 606.89 503.48 453.82 415.53 384.59 GP Margin 34.95% 36.77% 34.74% 32.33% 35.31% 41.40% 37.12% 34.62% 39.79% 38.17% 35.76% Total Expenditure 1,929.15 1,908.48 1,997.74 2,211.92 1,930.01 1,510.52 1,386.98 1,251.51 955.32 909.74 899.74 Power & Fuel Cost - 149.05 151.64 153.45 126.05 95.64 101.04 82.14 68.97 56.61 52.64 % Of Sales - 6.86% 6.69% 6.14% 5.60% 4.99% 6.18% 5.65% 6.05% 5.20% 4.89% Employee Cost - 73.88 70.20 64.30 57.17 55.60 52.65 47.23 45.12 42.76 36.93 % Of Sales - 3.40% 3.10% 2.57% 2.54% 2.90% 3.22% 3.25% 3.96% 3.93% 3.43% Manufacturing Exp. - 215.57 213.77 207.43 194.14 155.21 139.77 121.08 108.53 90.77 77.25 % Of Sales - 9.92% 9.43% 8.30% 8.62% 8.11% 8.55% 8.33% 9.52% 8.34% 7.18% General & Admin Exp. - 24.93 24.28 22.94 25.46 25.58 18.53 12.51 10.79 10.39 9.85 % Of Sales - 1.15% 1.07% 0.92% 1.13% 1.34% 1.13% 0.86% 0.95% 0.95% 0.92% Selling & Distn. Exp. - 62.18 50.95 67.67 65.68 52.73 41.55 34.95 31.58 30.35 27.78 % Of Sales - 2.86% 2.25% 2.71% 2.92% 2.75% 2.54% 2.40% 2.77% 2.79% 2.58% Miscellaneous Exp. - 8.37 7.52 5.68 5.24 3.67 5.40 2.83 3.69 5.67 27.78 % Of Sales - 0.39% 0.33% 0.23% 0.23% 0.19% 0.33% 0.19% 0.32% 0.52% 0.41% EBITDA 272.40 265.17 269.17 286.05 321.16 404.37 247.94 202.74 185.14 178.98 175.76 EBITDA Margin 12.37% 12.20% 11.87% 11.45% 14.27% 21.12% 15.17% 13.94% 16.23% 16.44% 16.34% Other Income 13.84 13.57 4.18 2.23 4.77 6.42 1.06 2.51 1.17 3.53 0.00 Interest 29.04 32.20 33.21 36.18 23.05 25.71 35.74 41.00 36.30 38.05 47.34 Depreciation 48.36 47.79 47.67 47.29 47.39 47.60 46.67 40.39 37.80 36.69 35.58 PBT 208.84 198.75 192.48 204.81 255.50 337.49 166.60 123.86 112.21 107.78 92.84 Tax 29.80 41.44 50.60 52.00 60.50 80.00 39.30 40.37 38.80 32.30 26.55 Tax Rate 14.27% 20.85% 26.29% 25.39% 23.68% 23.69% 22.46% 31.63% 34.58% 29.97% 28.60% PAT 179.04 157.31 141.88 152.81 195.00 257.71 135.67 87.26 73.41 75.48 66.29 PAT before Minority Interest 179.04 157.31 141.88 152.81 195.00 257.71 135.67 87.26 73.41 75.48 66.29 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.13% 7.24% 6.26% 6.12% 8.66% 13.46% 8.30% 6.00% 6.44% 6.93% 6.16% PAT Growth 38.52% 10.88% -7.15% -21.64% -24.33% 89.95% 55.48% 18.87% -2.74% 13.86% EPS 19.61 17.23 15.54 16.74 21.36 28.23 14.86 9.56 8.04 8.27 7.26

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,422.20 2,387.03 2,528.58 2,716.05 2,488.65 2,154.78 1,806.09 1,560.94 1,243.63 1,195.17 1,139.84 Net Sales Growth -0.03% -5.60% -6.90% 9.14% 15.49% 19.31% 15.71% 25.51% 4.05% 4.85% Cost Of Goods Sold 1,555.69 1,466.68 1,605.15 1,813.56 1,614.49 1,263.35 1,127.29 1,013.53 737.72 744.43 735.08 Gross Profit 866.51 920.35 923.42 902.50 874.15 891.43 678.79 547.40 505.91 450.75 404.77 GP Margin 35.77% 38.56% 36.52% 33.23% 35.13% 41.37% 37.58% 35.07% 40.68% 37.71% 35.51% Total Expenditure 2,126.02 2,096.80 2,207.74 2,406.60 2,156.05 1,714.40 1,540.57 1,350.03 1,041.76 1,004.68 960.02 Power & Fuel Cost - 152.01 154.31 156.10 128.34 98.20 103.83 84.39 71.42 59.42 53.93 % Of Sales - 6.37% 6.10% 5.75% 5.16% 4.56% 5.75% 5.41% 5.74% 4.97% 4.73% Employee Cost - 99.66 90.60 80.43 69.30 65.88 61.35 54.55 52.14 47.95 40.19 % Of Sales - 4.18% 3.58% 2.96% 2.78% 3.06% 3.40% 3.49% 4.19% 4.01% 3.53% Manufacturing Exp. - 259.20 252.91 241.58 230.56 181.41 160.38 142.69 130.01 103.21 87.60 % Of Sales - 10.86% 10.00% 8.89% 9.26% 8.42% 8.88% 9.14% 10.45% 8.64% 7.69% General & Admin Exp. - 32.41 29.50 28.79 30.42 29.03 21.39 14.24 12.22 12.81 10.98 % Of Sales - 1.36% 1.17% 1.06% 1.22% 1.35% 1.18% 0.91% 0.98% 1.07% 0.96% Selling & Distn. Exp. - 73.76 63.79 75.54 73.99 70.99 59.46 37.51 34.00 31.16 27.82 % Of Sales - 3.09% 2.52% 2.78% 2.97% 3.29% 3.29% 2.40% 2.73% 2.61% 2.44% Miscellaneous Exp. - 13.09 11.48 10.61 8.95 5.54 6.88 3.11 4.24 5.71 27.82 % Of Sales - 0.55% 0.45% 0.39% 0.36% 0.26% 0.38% 0.20% 0.34% 0.48% 0.39% EBITDA 296.18 290.23 320.84 309.45 332.60 440.38 265.52 210.91 201.87 190.49 179.82 EBITDA Margin 12.23% 12.16% 12.69% 11.39% 13.36% 20.44% 14.70% 13.51% 16.23% 15.94% 15.78% Other Income 15.56 16.36 4.03 2.19 11.32 4.53 1.48 2.41 1.05 4.00 0.00 Interest 35.72 39.04 37.89 37.14 23.91 26.23 37.42 43.51 38.36 40.02 48.02 Depreciation 57.12 55.78 51.45 50.32 50.05 49.88 48.75 42.56 40.06 38.46 36.53 PBT 218.90 211.77 235.53 224.18 269.96 368.79 180.82 127.26 124.50 116.01 95.27 Tax 30.11 43.67 63.94 57.82 64.96 88.62 43.89 41.27 42.20 34.21 26.55 Tax Rate 13.76% 20.62% 27.15% 25.79% 24.06% 24.02% 23.69% 31.50% 33.90% 29.49% 27.87% PAT 188.79 168.16 171.42 166.31 205.04 280.41 141.40 89.75 82.31 81.80 68.72 PAT before Minority Interest 188.82 168.10 171.59 166.36 205.00 280.40 141.40 89.75 82.31 81.80 68.72 Minority Interest 0.03 0.06 -0.17 -0.05 0.04 0.01 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.79% 7.04% 6.78% 6.12% 8.24% 13.01% 7.83% 5.75% 6.62% 6.84% 6.03% PAT Growth 20.33% -1.90% 3.07% -18.89% -26.88% 98.31% 57.55% 9.04% 0.62% 19.03% EPS 20.68 18.42 18.78 18.22 22.46 30.71 15.49 9.83 9.02 8.96 7.53

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,251.35 1,175.21 1,114.30 972.17 859.61 621.79 518.58 433.17 386.97 350.31 Share Capital 91.27 91.94 92.60 92.60 93.20 23.30 23.58 23.58 23.86 24.22 Total Reserves 1,160.08 1,083.27 1,021.70 879.57 766.41 598.49 494.99 409.59 363.11 326.10 Non-Current Liabilities 315.65 311.81 233.80 207.67 255.50 294.42 307.00 294.33 279.97 227.31 Secured Loans 234.38 234.69 153.32 109.76 138.99 167.71 186.69 173.99 173.28 160.64 Unsecured Loans 3.57 3.57 8.57 8.57 8.57 8.57 8.57 12.17 14.17 14.57 Long Term Provisions 3.44 2.74 2.98 7.86 22.12 25.12 12.80 16.87 8.66 1.42 Current Liabilities 705.79 684.60 847.39 854.68 521.89 554.49 547.36 588.74 449.18 477.08 Trade Payables 373.11 393.29 419.01 416.19 293.04 316.37 228.43 239.67 170.30 164.18 Other Current Liabilities 98.66 113.80 89.20 82.85 85.40 81.36 71.15 51.94 47.63 42.24 Short Term Borrowings 230.82 173.47 332.42 353.05 142.18 154.61 246.34 296.24 229.57 257.37 Short Term Provisions 3.20 4.03 6.76 2.59 1.28 2.14 1.43 0.89 1.68 13.28 Total Liabilities 2,272.79 2,171.62 2,195.49 2,034.52 1,637.00 1,470.70 1,372.94 1,316.24 1,116.12 1,054.70 Net Block 761.23 722.29 634.48 649.41 630.52 611.57 585.67 563.59 542.32 462.77 Gross Block 1,360.74 1,276.97 1,141.49 1,112.42 1,052.68 987.49 920.74 862.31 803.53 690.74 Accumulated Depreciation 599.50 554.67 507.00 463.01 422.16 375.92 335.07 298.72 261.21 227.97 Non Current Assets 1,092.23 990.60 845.96 761.33 676.88 645.33 637.93 619.59 586.64 512.67 Capital Work in Progress 273.40 221.62 160.75 59.62 15.95 10.96 32.37 27.99 14.13 34.04 Non Current Investment 42.40 29.97 28.62 28.03 24.32 20.38 18.92 17.24 18.42 11.12 Long Term Loans & Adv. 15.20 16.71 22.11 24.26 6.09 2.42 0.97 10.77 11.76 4.74 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,180.56 1,181.02 1,349.53 1,273.19 960.13 825.36 735.00 696.65 529.48 542.03 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 407.23 441.77 477.73 488.46 390.38 307.41 227.71 254.10 188.75 167.05 Sundry Debtors 701.72 643.95 801.68 711.64 503.99 464.34 436.90 365.23 278.27 321.19 Cash & Bank 4.57 3.82 2.68 2.21 3.81 3.85 4.85 3.91 4.00 4.50 Other Current Assets 67.03 2.81 2.62 0.70 61.96 49.77 65.56 73.40 58.45 49.28 Short Term Loans & Adv. 63.98 88.67 64.83 70.18 59.52 47.50 59.00 63.19 58.45 49.28 Net Current Assets 474.77 496.42 502.14 418.52 438.23 270.88 187.65 107.92 80.30 64.95 Total Assets 2,272.79 2,171.62 2,195.49 2,034.52 1,637.01 1,470.69 1,372.93 1,316.24 1,116.12 1,054.70

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,369.00 1,281.55 1,192.43 1,036.36 913.42 652.49 543.45 455.43 400.13 357.40 Share Capital 91.27 91.94 92.60 92.60 93.20 23.30 23.58 23.58 23.86 24.22 Total Reserves 1,277.73 1,189.61 1,099.83 943.76 820.22 629.19 519.86 431.85 376.27 333.18 Non-Current Liabilities 368.37 354.86 279.25 231.60 257.25 300.82 321.06 312.31 296.59 243.78 Secured Loans 280.43 271.76 196.11 129.93 138.99 171.74 199.64 190.53 187.38 176.66 Unsecured Loans 3.57 3.57 8.57 8.57 8.57 8.57 8.57 12.17 14.17 14.57 Long Term Provisions 4.33 2.74 3.03 9.23 21.67 25.13 12.32 16.87 8.39 1.42 Current Liabilities 836.97 795.54 949.48 940.06 595.36 623.19 590.98 621.68 494.31 501.02 Trade Payables 416.14 425.49 480.27 468.67 329.97 329.55 242.63 258.73 196.97 184.90 Other Current Liabilities 144.70 151.21 100.07 111.33 105.38 132.83 82.94 56.42 51.00 43.80 Short Term Borrowings 271.83 214.70 360.55 356.34 157.21 157.73 263.25 305.64 244.66 258.41 Short Term Provisions 4.29 4.13 8.60 3.71 2.80 3.08 2.16 0.89 1.68 13.91 Total Liabilities 2,574.68 2,432.36 2,421.39 2,207.96 1,766.01 1,576.50 1,455.49 1,389.42 1,191.03 1,102.20 Net Block 866.11 811.09 676.23 689.93 665.40 643.81 624.86 602.39 581.09 493.42 Gross Block 1,495.70 1,388.16 1,202.18 1,169.00 1,101.02 1,030.97 970.09 909.20 848.13 725.47 Accumulated Depreciation 629.59 577.07 525.96 479.06 435.62 387.16 345.22 306.81 267.04 232.05 Non Current Assets 1,236.32 1,111.64 929.61 814.59 709.22 672.50 671.20 652.55 619.61 536.97 Capital Work in Progress 330.18 260.87 210.35 76.74 19.26 12.21 32.75 28.45 14.28 34.04 Non Current Investment 22.41 19.97 18.80 19.48 17.30 13.36 12.44 10.76 11.94 4.63 Long Term Loans & Adv. 17.62 19.70 24.23 28.44 7.26 3.12 1.15 10.95 12.30 4.88 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,338.35 1,320.72 1,491.79 1,393.37 1,056.80 904.00 784.29 736.86 571.42 565.23 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 472.93 485.89 516.29 525.94 415.00 325.40 246.61 278.21 209.63 178.35 Sundry Debtors 751.18 704.55 864.84 749.90 555.23 488.63 458.54 374.94 296.81 331.69 Cash & Bank 7.56 9.43 8.96 22.33 9.78 7.64 5.55 4.27 4.17 4.82 Other Current Assets 106.69 3.23 3.04 0.70 76.79 82.32 73.58 79.44 60.81 50.37 Short Term Loans & Adv. 102.77 117.61 98.66 94.50 74.35 75.50 67.02 69.23 60.81 50.37 Net Current Assets 501.39 525.18 542.31 453.31 461.44 280.81 193.31 115.19 77.11 64.20 Total Assets 2,574.67 2,432.36 2,421.40 2,207.96 1,766.02 1,576.50 1,455.49 1,389.41 1,191.03 1,102.20

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 220.08 337.10 161.70 39.90 154.18 196.15 147.30 61.93 174.41 125.27 PBT 198.75 192.48 204.81 255.50 337.71 174.97 127.62 112.21 107.78 92.84 Adjustment 70.08 77.69 78.43 66.76 65.35 79.82 70.77 71.06 68.20 78.20 Changes in Working Capital 3.19 118.17 -66.71 -202.27 -161.11 -21.34 -22.19 -99.42 17.93 -25.75 Cash after chg. in Working capital 272.03 388.34 216.53 119.99 241.95 233.46 176.21 83.85 193.91 145.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -51.95 -51.23 -54.83 -80.09 -87.78 -37.32 -28.91 -21.92 -19.51 -20.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -134.92 -187.09 -131.14 -125.36 -69.03 -29.35 -59.33 -71.09 -96.29 -87.40 Net Fixed Assets -135.55 -196.35 -130.20 -103.41 -70.18 -45.34 -62.81 -72.64 -92.88 -46.34 Net Investments -12.43 -1.35 -0.59 -3.71 -3.94 -1.46 -1.68 1.18 -7.30 -0.01 Others 13.06 10.61 -0.35 -18.24 5.09 17.45 5.16 0.37 3.89 -41.05 Cash from Financing Activity -84.60 -148.81 -30.54 84.11 -85.28 -167.76 -86.96 9.12 -78.42 -36.79 Net Cash Inflow / Outflow 0.56 1.20 0.03 -1.35 -0.13 -0.96 1.01 -0.04 -0.31 1.07 Opening Cash & Equivalents 2.72 1.52 1.49 2.84 2.98 3.94 2.93 2.97 3.28 3.43 Closing Cash & Equivalent 3.28 2.72 1.52 1.49 2.84 2.98 3.94 2.93 2.97 4.50

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 244.58 358.92 133.32 70.41 154.95 250.74 143.09 69.77 174.75 133.29 PBT 211.77 235.53 224.18 269.96 369.01 185.29 131.02 124.50 116.01 95.27 Adjustment 84.34 83.01 85.15 71.19 68.60 86.84 75.20 75.12 71.63 79.30 Changes in Working Capital 3.59 102.78 -116.34 -187.35 -185.99 19.49 -33.49 -105.19 8.47 -21.25 Cash after chg. in Working capital 299.70 421.32 193.00 153.79 251.63 291.62 172.74 94.44 196.11 153.33 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -55.12 -62.40 -59.67 -83.38 -96.68 -40.88 -29.64 -24.67 -21.36 -20.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -164.63 -223.65 -163.97 -149.64 -71.78 -33.21 -61.67 -73.54 -106.98 -98.79 Net Fixed Assets -135.55 -196.35 -130.20 -103.41 -70.18 -45.34 -62.81 -72.64 -92.88 -46.34 Net Investments -12.43 -1.35 -0.59 -3.71 -3.94 -1.46 -1.68 1.18 -7.30 -0.01 Others -16.65 -25.95 -33.18 -42.52 2.34 13.59 2.82 -2.08 -6.80 -52.44 Cash from Financing Activity -82.12 -136.03 16.54 92.03 -81.13 -215.41 -80.07 3.92 -68.23 -33.26 Net Cash Inflow / Outflow -2.17 -0.76 -14.11 12.80 2.04 2.13 1.35 0.15 -0.45 1.24 Opening Cash & Equivalents 6.74 7.50 21.61 8.81 6.77 4.64 3.29 3.15 3.60 3.58 Closing Cash & Equivalent 4.58 6.74 7.50 21.61 8.81 6.77 4.64 3.29 3.15 4.82

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 137.10 127.83 120.34 104.99 92.23 66.72 54.98 45.92 40.55 36.16 ROA 7.08% 6.50% 7.23% 10.62% 16.59% 9.54% 6.49% 6.04% 6.95% 6.56% ROE 12.97% 12.39% 14.65% 21.29% 34.79% 23.79% 18.34% 17.90% 20.47% 20.27% ROCE 13.53% 13.70% 15.38% 20.82% 33.35% 21.29% 17.39% 16.64% 18.03% 18.43% Fixed Asset Turnover 1.65 1.87 2.22 2.08 1.88 1.71 1.63 1.39 1.59 1.73 Receivable days 112.98 116.38 110.56 98.55 92.29 100.60 100.66 101.27 92.25 98.01 Inventory Days 71.28 74.02 70.59 71.25 66.50 59.73 60.46 69.69 54.75 49.94 Payable days 101.76 100.21 90.17 88.88 99.12 67.96 68.73 71.92 65.41 62.49 Cash Conversion Cycle 82.51 90.20 90.98 80.91 59.67 92.38 92.40 99.04 81.59 85.46 Total Debt/Equity 0.41 0.40 0.48 0.53 0.38 0.59 0.91 1.19 1.16 1.23 Interest Cover 7.17 6.80 6.66 12.08 14.13 5.90 4.11 4.09 3.83 2.96

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 149.99 139.40 128.77 111.92 98.01 70.01 57.61 48.28 41.93 36.90 ROA 6.71% 7.07% 7.19% 10.32% 16.78% 9.33% 6.31% 6.38% 7.13% 6.53% ROE 12.68% 13.87% 14.93% 21.03% 35.81% 23.65% 17.97% 19.24% 21.60% 20.65% ROCE 13.11% 15.01% 15.49% 20.75% 34.52% 21.39% 17.01% 17.31% 18.50% 18.33% Fixed Asset Turnover 1.66 1.95 2.29 2.19 2.02 1.81 1.66 1.44 1.64 1.75 Receivable days 111.30 113.27 108.50 95.71 88.41 95.71 97.45 97.10 89.05 95.59 Inventory Days 73.31 72.33 70.03 69.00 62.71 57.80 61.36 70.52 54.97 50.69 Payable days 104.72 102.98 95.49 90.28 95.27 64.68 68.08 73.82 67.66 65.68 Cash Conversion Cycle 79.88 82.62 83.04 74.43 55.85 88.83 90.73 93.79 76.36 80.60 Total Debt/Equity 0.45 0.44 0.51 0.52 0.38 0.58 0.93 1.20 1.20 1.26 Interest Cover 6.42 7.22 7.04 12.29 15.07 5.95 4.01 4.25 3.90 2.98

Top Investors:

dsp small cap fund

harit pragji shah

jayshree harit shah

icici prudential pharma healthcare and diaganostics (p.h.d) fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Aarti Drugs commences commercial production at Gujarat manufacturing plant
5th Sep 2025, 12:21 PM

The facility will manufacture Dimethylamine, Monomethylamine, Trimethylamine, and their derivatives
Read More
Aarti Drugs - Quarterly Results
18th Jul 2025, 16:40 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback